These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 11748475

  • 21. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
    Rogala E, Skopińska-Rózewska E, Sommer E, Pastewka K, Chorostowska-Wynimko J, Sokolnicka I, Kazoń M.
    Anticancer Res; 2001; 21(6B):4259-63. PubMed ID: 11908679
    [Abstract] [Full Text] [Related]

  • 22. Occurrence of hematogenous metastasis and serum levels of thymidine phosphorylase in colorectal cancer.
    Haraguchi M, Komuta K, Akashi A, Furui J, Kanematsu T.
    Oncol Rep; 2003; 10(5):1207-12. PubMed ID: 12883682
    [Abstract] [Full Text] [Related]

  • 23. Tissue factor expression and metastatic potential of colorectal cancer.
    Shigemori C, Wada H, Matsumoto K, Shiku H, Nakamura S, Suzuki H.
    Thromb Haemost; 1998 Dec; 80(6):894-8. PubMed ID: 9869156
    [Abstract] [Full Text] [Related]

  • 24. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Poon RT, Lau CP, Cheung ST, Yu WC, Fan ST.
    Cancer Res; 2003 Jun 15; 63(12):3121-6. PubMed ID: 12810638
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Correlations between cyclooxygenase-2 expression and angiogenic factors in primary tumors and liver metastases in colorectal cancer.
    Nakamoto RH, Uetake H, Iida S, Kolev YV, Soumaoro LT, Takagi Y, Yasuno M, Sugihara K.
    Jpn J Clin Oncol; 2007 Sep 15; 37(9):679-85. PubMed ID: 17846040
    [Abstract] [Full Text] [Related]

  • 30. Differential assessment of vascular survival ability and tumor angiogenic activity in colorectal cancer.
    Giatromanolaki A, Sivridis E, Minopoulos G, Polychronidis A, Manolas C, Simopoulos C, Koukourakis MI.
    Clin Cancer Res; 2002 May 15; 8(5):1185-91. PubMed ID: 12006536
    [Abstract] [Full Text] [Related]

  • 31. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K, Yamashita K, Hirai K, Kumamoto H, Sato T, Ozawa H, Nakamura T, Onozato W, Kokuba Y, Ihara A, Watanabe M.
    Oncol Rep; 2008 Oct 15; 20(4):737-43. PubMed ID: 18813812
    [Abstract] [Full Text] [Related]

  • 32. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
    Tsai WS, Changchien CR, Yeh CY, Chen JS, Tang R, Chiang JM, Hsieh PS, Fan CW, Wang JY.
    Dis Colon Rectum; 2006 Jun 15; 49(6):883-94. PubMed ID: 16741643
    [Abstract] [Full Text] [Related]

  • 33. [The relationship between plasma level of VEGF or soluble Flt-1 and efficacy of hepatic arterial chemotherapy in patients with liver metastasis of colorectal cancer].
    Gonda T, Okada N, Nakada H, Yokoyama M, Miyazaki T, Ishibashi K, Ishida H, Matsumoto Y, Miura T.
    Gan To Kagaku Ryoho; 2006 Nov 15; 33(12):1841-4. PubMed ID: 17212123
    [Abstract] [Full Text] [Related]

  • 34. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF, Wu XH, Zhu Y, Shi GS, Dong ZZ, Yao DB, Wu W, Qiu LW, Meng XY.
    Hepatobiliary Pancreat Dis Int; 2005 May 15; 4(2):220-6. PubMed ID: 15908319
    [Abstract] [Full Text] [Related]

  • 35. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
    Tsushima H, Ito N, Tamura S, Matsuda Y, Inada M, Yabuuchi I, Imai Y, Nagashima R, Misawa H, Takeda H, Matsuzawa Y, Kawata S.
    Clin Cancer Res; 2001 May 15; 7(5):1258-62. PubMed ID: 11350892
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Association of interleukin-8 and plasminogen activator system in the progression of colorectal cancer.
    Terada H, Urano T, Konno H.
    Eur Surg Res; 2005 May 15; 37(3):166-72. PubMed ID: 16088182
    [Abstract] [Full Text] [Related]

  • 38. [Liver metastasis in colorectal cancer and tumor angiogenesis].
    Xie Z, Huang X, Li J, Zhou L.
    Zhonghua Wai Ke Za Zhi; 1999 Jun 15; 37(6):336-7, 21. PubMed ID: 11829853
    [Abstract] [Full Text] [Related]

  • 39. Prognostic role of angiogenesis in colorectal cancer.
    Papamichael D.
    Anticancer Res; 2001 Jun 15; 21(6B):4349-53. PubMed ID: 11908690
    [Abstract] [Full Text] [Related]

  • 40. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
    La Rosa S, Uccella S, Finzi G, Albarello L, Sessa F, Capella C.
    Hum Pathol; 2003 Jan 15; 34(1):18-27. PubMed ID: 12605362
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.